Gabriel Vangompel, DPM
Podiatrist · Fremont, CANPI 1497017040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 43.5% of the total. That places this record below the midpoint for podiatrist clinicians in CA, where the typical reported total is $730.
Across 7 payments — averaging $28.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$86
- Aap Implants Inc$28
- Crossroads Extremity Systems, LLC$22
- Stryker$18
- Convatec Inc.$16
- Orthofix Medical, Inc.$16
- plus $11 from 1 others
What the payments were for
- Food & beverage$197100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $86 |
| Aap Implants Inc | 1 | $28 |
| Crossroads Extremity Systems, LLC | 1 | $22 |
| Stryker | 1 | $18 |
| Convatec Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $16 |
| Arthrosurface Incorporated | 1 | $11 |
How this compares
$197 in reported general payments places this provider in the 25th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 12 | $1,084 |
| Diclofenac Sodium | 24 | $499 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Fremont
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.